Immune Dysregulation in Children and Adults With Asthma

• Status: Completed
• Trial end date: 2001-11-01
• Target enrollment: 0
• Participant gender: All

Summary

To immunize both normal and asthmatic subjects with a neoantigen, keyhole limpet hemocyanin (KLH) and observe the type of antibody and T cell response that develops.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of New Mexico
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Budesonide; Nedocromil

Criteria

No eligibility criteria